20899 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Tetrapeptides
Peptide Amide Composition and Preparation Method Therefor
#2ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES
#3METHODS FOR TREATING CANCERS ASSOCIATED WITH ETBR ACTIVATION
#4LIPOSOME COMPOSITIONS FOR DELIVERY OF COMPOUNDS AND METHODS THEREOF
#5SAPOSIN-A DERIVED PEPTIDES AND USES THEREOF
#6COMPOSITIONS AND METHODS FOR TREATING DEGENERATIVE, AGE-RELATED AND TRAUMA-INDUCED DISORDERS
#7PEPTIDE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF SKIN AND MUCOUS MEMBRANE WOUNDS AND IN COSMETIC APPLICATIONS
#8Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis
#9METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BARTH SYNDROME
#10DIELS-ALDER CONJUGATION METHODS
#11SYNERGISTIC INTERACTIONS FOR IMPROVED CANCER TREATMENT
#12DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION
#13STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION
#14GRANULAR COMPOSITIONS COMPRISING A PEPTIDE AND USES THEREOF
#15STABLE READY TO DILUTE COMPOSITION OF CARFILZOMIB
#16PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-191P4D12 ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF
#17TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#18PHOSPHORYLCHOLINE-TUFTSIN CONJUGATE FOR TREATING OCULAR INFLAMMATION
#19FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS
#20PEPTIDE-IONIC LIQUID CONJUGATE FOR THE PREVENTION AND/OR TREATMENT OF SKIN DISORDERS
#21POLYPEPTIDES HAVING ANTI-INFLAMMATORY EFFECTS AND USES THEREOF
#22STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION
#23COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE CONTAINING NOVEL COMPOUND
#24METHODS OF TREATING ULK3-ASSOCIATED CANCERS
#25METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#26PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#27METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS
#28NITROGEN-CONTAINING ANALOGS OF SALINOMYCIN FOR USE IN MULTIPLE MYELOMA (MM)
#29METHODS OF MITIGATING MYOCARDIAL DAMAGE DUE TO EXTRACORPOREAL MEMBRANE OXYGENATION
#30METHODS FOR REDUCING CD36 EXPRESSION
#31PEPTIDES AND METHODS OF USE THEREOF IN TREATING SKIN DISEASES
#32METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#33METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH
#34ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#35POLYPEPTIDES HAVING ANTI-SENESCENT EFFECTS AND USES THEREOF
#36USE OF SODIUM TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] TO AMELIORATE PROTEASOME INHIBITOR RESISTANCE
#37DR5 Agonist and PLK1 Inhibitor or CDK Inhibitor Combination Therapy
#38TARGET SUBSTRATE PROTEIN DEGRADATION PLATFORM
#39BIVALIRUDIN COMPOUNDS
#40OPHTALMIC COMPOSITIONS AND METHODS OF USING SAME
#41THERAPEUTIC AGENT FOR OVARIAN CLEAR CELL CARCINOMA
#42STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS
#43ANTI-ROR2 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF
#44CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#45METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#46Drug-Conjugates, Conjugation Methods, And Uses Thereof
#47PROCESSES FOR PREPARING FUNCTIONALIZED CYCLOOCTENES
#48TRI-, TETRA AND PENTAPEPTIDES, COMPOSITIONS THEREOF AND THEIR USE IN THE THERAPY OF PSORIASIS
#49METHODS OF TREATING ACUTE DEPRESSION AND ANXIETY
#50SCALP-DERIVED PEPTIDES ALLEVIATING HAIR LOSS SYMPTOMS
#51METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#52ANTI-MESOTHELIN ANTIBODY AND ANTIBODY DRUG CONJUGATE THEREOF
#53CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONAMIDATES
#54METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#55ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS
#56Methods and Compositions for Delivery of Biotin to Mitochondria
#57MODIFIED OLIGONUCLEOTIDE-DRUG CONJUGATE AND USE THEREOF
#58LIQUID COMPOSITIONS COMPRISING A PHOSPHORYLCHOLINE-TUFTSIN CONJUGATE
#59COMBINATION THERAPY FOR CANCER
#60COMBINATION THERAPY FOR THE TREATMENT OF FRIEDREICH'S ATAXIA
#61METHOD OF CARDIOPROTECTION
#62IRAP INHIBITORS FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES
#63COMPOSITIONS AND METHODS OF ALLEVIATING RESISTANCE TO CHEMOTHERAPY
#64AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#65REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES
#66Polypeptide and its use as a CCK receptor agonist/antagonist
#67ASSESSING AND TREATING MULTIPLE MYELOMA
#68COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS
#69METHODS AND COMPOSITIONS FOR TREATING DNMT3A DEFICIENCY-ASSOCIATED DISEASES
#70PEPTIDE-CONTAINING LINKERS FOR ANTIBODY-DRUG CONJUGATES
#71EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE
#72PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
#73METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOL DEPENDENCE
#74PEPTIDES WITH ANTI-ANGIOGENIC ACTIVITY
#75PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY SKIN DISEASE
#76GRP78-BINDING ANTIBODIES AND USE THEREOF IN DETECTING OR NEUTRALIZING GRP78
#77OCULAR ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF
#78COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF VASCULAR MALFORMATIONS
#79THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS
#80COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#81PEPTIDES AND METHODS OF TREATING DYSTROPHY-RELATED DISORDERS USING THE SAME
#82SULFOMALEIMIDE-BASED LINKERS AND CORRESPONDING CONJUGATES
#83COMPOSITIONS AND METHOD FOR TREATING ACUTE RADIATION SYNDROME
#84METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY
#85Systems and Methods for Treating an Opioid-Induced Adverse Pharmacodynamic Response
#86COVALENT HETEROBIVALENT ANTIBODY INHIBITORS AND LIGANDS
#87Sulfatase-Cleavable Linkers for Antibody-Drug Conjugates
#88Polypeptides having anti-senescent effects and uses thereof
#89CONTROLLING PRO-INFLAMMATORY MACROPHAGE PHENOTYPE THROUGH BIOFUNCTIONAL HYDROGEL DESIGN
#90CANCER THERAPEUTICS
#91METHODS OF REDUCING NEUROPATHY AND NEUROPATHIC SYMPTOMS AND TREATING CANCER
#92TOPICAL COMPOSITIONS
#93Treatment for Skeletal Diseases Caused by Intracellular Protein Trafficking Defects
#94ADDRESSING INJECTION SITE REACTIONS ASSOCIATED WITH THE ADMINISTRATION OF ELAMIPRETIDE
#95INHIBITORS OF KRAS G12C AND METHODS OF USING THE SAME
#96ASSESSING AND TREATING PROSTATE CANCER
#97METHODS FOR INHIBITING RAS
#98STABLE READY TO DILUTE COMPOSITION OF CARFILZOMIB
#99RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS
#100TOPICAL AND PARENTERAL USE AND ADMINISTRATION OF SELF-ASSEMBLING AMPHIPHILIC PEPTIDE HYDROGELS
#101BETA-GLUCURONIDE-LINKER DRUG CONJUGATES
#102METHODS FOR TREATING AMBLYOPIA
#103COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY DISTRESS
#104NOVEL METHODS
#105NANOCONSTRUCTS AND NANOPARTICLE-MEDIATED DELIVERY OF IMMUNOGENIC CELL DEATH INDUCERS FOR ENHANCING CANCER IMMUNOTHERAPY
#106KAPPA-OPIOID RECEPTOR AGONIST IMPLANTS FOR TREATMENT OF PRURITUS
#107TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#108DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
#109COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS
#110DIELS-ALDER CONJUGATION METHODS
#111USE OF PEPTIDE AMIDE COMPOUND IN PREPARATION OF DRUG FOR TREATING PRURITUS
#112COMPOSITIONS AND METHODS FOR MODULATING MAMMARY DISORDERS AND CONDITIONS
#113POLYPEPTIDE HAVING MMP2-INHIBITORY EFFECT
#114PROCESS FOR THE PREPARATION OF PEGYLATED DRUG-LINKERS AND INTERMEDIATES THEREOF
#115ANTIMICROBIAL PEPTIDE STIMULATING SANITIZING COMPOSITION
#116SILICA-BASED FORMULATIONS OF THERAPEUTIC OLIOGPEPTIDES AND PEPTIDOMIMETICS
#117BRUISING AND FILLER COMPOSITIONS AND METHODS FOR USE
#118BCL-2 INHIBITORS
#119USE OF KAPPA OPIOID RECEPTOR AGONISTS TO TREAT CARDIOVASCULAR DISEASE
#120KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#121CHEMOTACTIC AUTOPHAGY-INHIBITING PEPTIDE, COMPOSITIONS AND METHODS RELATED THERETO
#122METHODS OF TREATING CANCER WITH NONFUCOSYLATED ANTI-CD70 ANTIBODIES
#123STABLE ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND USE THEREOF
#124STABLE ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND USE THEREOF
#125Methods and compositions for the prevention or treatment of Barth Syndrome
#126TREATMENT OF CANCER WITH TG02
#127SITE SPECIFIC ANTIBODY-DRUG CONJUGATES WITH PEPTIDE-CONTAINING LINKERS
#128TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#129TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#130PEPTIDES FOR TREATING DISEASE AND REDUCING SYMPTOMS RELATED TO MULTIPLE SCLEROSIS
#131USE OF PROTEASOME INHIBITORS IN THE TREATMENT OF CORONAVIRUS INFECTIONS
#132METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA
#133Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof
#134Anti-αVβ6 antibodies and antibody-drug conjugates
#135REPOSITIONING THE ANTI-LEPROSY DRUG CLOFAZIMINE AGAINST DRUG-RESISTANT MYELOMA AND PUTATIVE STEM-CELL SUBCLONES
#136Topical Hyperpigmentation Compositions and Method of Use
#137COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES
#138SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION
#139USE OF COMPOUND, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IMMUNE OR METABOLIC DISORDERS, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ILLNESSES CAUSED BY OR ASSOCIATED WITH VIRUSES
#140IMMUNOSTIMULATORY METHOD
#141SYNERGISTIC TETRAPEPTIDE COMBINATION
#142N-f-MLF DERIVATIVES THAT INHIBIT FORMYL PEPTIDE RECEPTORS FOR THE TREATMENT OF DISEASE
#143METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#144Methods For The Effective Treatment Of Metastatic Cancer
#145THERAPEUTIC ANTIBODIES AND THEIR USES
#146COMPOSITIONS AND METHODS FOR BODY CONTOURING AND SURGICAL PROCEDURES
#147TG2 INHIBITORS FOR IMPROVING MUCOCILIARY CLEARANCE IN RESPIRATORY DISEASES
#148INHIBITION OF CASPASE PATHWAY AS A TREATMENT FOR LYSOSOMAL STORAGE DISORDERS
#149METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
#150HAIR GROWTH AGENT
#151Remote loading of sparingly water-soluble drugs into lipid vesicles
#152OLIGOSACCHARIDE FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS
#153Methods and compositions for preventing or treating ophthalmic conditions
#154PHOSPHORYLCHOLINE-TUFTSIN CONJUGATE FOR TREATING OCULAR INFLAMMATION
#155TREATMENT OF HMGB1-MEDIATED INFLAMMATION
#156DISCOVERY OF YEATS2 YEATS DOMAIN INHIBITORS AS NOVEL ANTI-CANCER AGENTS
#157Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
#158Compositions and methods for improving bruising and rejuvenating skin
#159METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
#160ORAL FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS
#161PHOSPHORYLCHOLINE CONJUGATES AND USES THEREOF
#162Method for treating gingivitis and gingival atrophy and repairing oral mucosa
#163METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#164Saposin-A derived peptides and uses thereof
#165Compositions and Methods for Gene Therapy for Corneal Endothelium Disorders
#166Methods for the prevention or treatment of heart failure
#167TREATMENTS FOR CANCERS HAVING KRAS MUTATIONS
#168ATOPIC DERMATITIS THERAPY WITH KAPPA OPIOID RECEPTOR AGONIST AS ADJUNCT TO TOPICAL CORTICOSTEROID
#169METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#170METHODS OF PROGNOSING, DETERMINING TREATMENT COURSE AND TREATING MULTIPLE MYELOMA
#171BIOMARKER BASED PATIENT SELECTION FOR PROTEASOME INHIBITOR TREATMENT
#172ANTIVIRAL USE OF LIRAGLUTIDE AND GEFITINIB
#173METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULAR DYSTROPHY
#174Compositions and Methods for Treating Granulomatosis with Polyangiitis
#175METHODS AND MEANS FOR MODIFYING HEMODYNAMICS IN INFECTIONS
#176IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
#177EFFECTIVE TREATMENTS FOR VASCULAR ASSOCIATED MACULOPATHY, SEVERE MACULOPATHY, LATE-STAGE MACULOPATHY, AND ABERRANT CHORIOCAPILLARIS
#178COMPOSITIONS AND METHODS FOR TREATMENT
#179PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#180Methods and compositions for delivery of biotin to mitochondria
#181Novel Therapeutic Uses of Mu-Opiate Receptor Peptides
#182METHODS FOR REDUCING CD36 EXPRESSION
#183Methods and compositions for delivery of biotin to mitochondria
#184METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS
#185LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#186PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING ANTIVIRAL AGENT AND ANTIDEPRESSANT AS ACTIVE INGREDIENTS
#187METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH
#188COMPOSITIONS AND METHODS TO TREAT POLYCYSTIC KIDNEY DISEASE
#189ORAL PHARMACEUTICAL COMPOSITION
#190A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS
#191CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS
#192STABLE READY TO DILUTE FORMULATIONS OF CARFILZOMIB
#193HMGB1 antagonist treatment of severe sepsis
#194CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS
#195METHODS FOR REDUCING OXIDATIVE DAMAGE
#196SMAC mimetic
#197Compositions and methods for the treatment and prevention of vascular malformations
#198Phage-displayed accessible recombinant targeted antibodies and methods of making same
#199MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#200MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#201ANTIBODY-CONJUGATES WITH IMPROVED THERAPEUTIC INDEX FOR TARGETING HER2 TUMOURS AND METHOD FOR IMPROVING THERAPEUTIC INDEX OF ANTIBODY-CONJUGATES
#202PEPTIDES AND PHARMACEUTICAL, NUTRACEUTICAL OR VETERINARY COMPOSITIONS FOR HAIR LOSS PREVENTION AND/OR TREATMENT
#203METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#204Cosmetic compositions
#205MICELLES AND VESICLES FOR THE DELIVERY OF GLYCOPEPTIDES
#206ENHANCEMENT OF CD47 BLOCKADE THERAPY BY PROTEASOME INHIBITORS
#207ANTICANCER AGENT CONTAINING RHOA PEPTIDE INHIBITOR AS AN ACTIVE INGREDIENT
#208TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR USE IN COMBINATION THERAPY
#209ENHANCING EXPRESSION OF LINE-1 ENCODED ORF2P FOR CANCER THERAPEUTICS
#210STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS
#211METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE
#212Methods and compositions for delivery of biotin to mitochondria
#213Peptide-containing linkers for antibody-drug conjugates
#214GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78
#215DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#216TREATMENT OF CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS
#217SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME
#218COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES
#219ANTIVIRAL PEPTOID COMPOSITIONS
#220ALLOSTERIC MODULATORS OF THE MU OPIOID RECEPTOR
#221COMPOSITIONS AND METHODS FOR CANCER TREATMENT BY ENHANCING ANTITUMOR IMMUNITY USING TANNIC ACID-BASED NANOCAPSULES
#222PHARMACEUTICAL COMPOSITIONS FOR INHIBITING INFLAMMATORY CYTOKINES
#223Diels-alder conjugation methods
#224METHODS OF CONJUGATING AN AGENT TO A THIOL MOIETY IN A PROTEIN THAT CONTAINS AT LEAST ONE TRISULFIDE BOND
#225METHODS OF TREATMENT FOR MODIFYING HEMODYNAMICS
#226COMPOSITIONS AND METHODS FOR TREATING DEGENERATIVE, AGE-RELATED AND TRAUMA-INDUCED DISORDERS
#227Topical compositions
#228PEPTIDES FOR TREATMENT OF MEDICAL DISORDERS
#229GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78
#230PEPTIDE PHARMACEUTICALS
#231Methods and compositions for delivery of biotin to mitochondria
#232DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION
#233METHOD FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME USING AN INHIBITORY OR CYTOTOXIC AGENT AGAINST PLASMA CELLS
#234Use of interference peptide in preparation of anti-SARS-CoV-2 medicament
#235USE OF A COMPOSITION CONTAINING AN EXTRACT OF TULIPA GESNERIANA
#236GRP78-binding antibodies and uses thereof and selection of phage-displayed accessible recombinant targeted antibodies
#237Antibody drug conjugates for ablating hematopoietic stem cells
#238PEPTIDE AMIDE COMPOSITION AND PREPARATION METHOD THEREFOR
#239METHOD OF ENHANCING A BRAIN OR COGNITIVE FUNCTION
#240Methods and compositions for increasing the dose of a chemotherapeutic agent
#241Immunostimulatory method
#242TREATMENT
#243COMPOSITIONS COMPRISING ENZYME-CLEAVABLE PRODRUGS AND CONTROLLED RELEASE NAFAMOSTAT AND METHODS OF USE THEREOF
#244ANTIBODIES THAT BIND TO LRP6 PROTEINS AND METHODS OF USE
#245METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#246CHOLECYSTOKININ B RECEPTOR TARGETING FOR IMAGING AND THERAPY
#247SS-31 FOR THE PREVENTION AND/OR TREATMENT OF ANEURYSM
#248PHARMACEUTICAL FORMULATIONS COMPRISING SODIUM PALMITOYL-L-PROLYL-L-PROLYLGLYCYL-L-TYROSINATE AND METHODS FOR PREPARING THE SAME
#249COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#250DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES
#251CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#252Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers
#253INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION
#254COMPOSITIONS AND METHODS FOR TREATING ACUTE RADIATION SYNDROME
#255Materials and Methods for Treatment of Inflammation
#256QUINAZOLINYL COMPOUNDS AND METHODS OF USE
#257Composition and Concentrate for Use in Preparation of Dialysis Solution, Corresponding Dialysis Solution and Combinations Comprising Container
#258Peptide for treating sepsis derived from Rv2626c protein of
#259Inhibitors of KRAS G12C and methods of using the same
#260DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES
#261METHODS AND COMPOSITIONS FOR TRANSGENE EXPRESSION
#262AMPK/CASPASE-6 AXIS CONTROLS LIVER DAMAGE IN NONALCOHOLIC STEATOHEPATITIS
#263Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof
#264Synthetic neuromodulatory peptides
#265THERMOGENIC COMPOSITIONS AND METHODS
#266Anti-ROR2 antibodies, antibody fragments, their immunoconjucates and uses thereof
#267Lipoprotein targeting protease inhibitors and uses
#268SELF-ASSEMBLING PEPTIDES AS BRONCHIAL OBSTRUCTION AGENTS
#269AMHRII-BINDING COMPOUNDS FOR PREVENTING OR TREATING CANCERS
#270BETA-GLUCURONIDE-LINKER DRUG CONJUGATES
#271PEPTIDE ANALOGUES WITH BRANCHED AMINO ACID PROBE(S)
#272COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS
#273CD38 Antibody Drug Conjugate
#274Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
#275ENCAPSULATED GLYCOLIPID ANTIGENS FOR TREATMENT OF NEOPLASTIC DISEASES
#276BELANTAMAB MAFODOTIN IN COMBINATION WITH PEMBROLIZUMAB FOR TREATING CANCER
#277COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#278COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB
#279Functionalized poly-ADP-ribose polymers for drug delivery
#280BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP
#281Ready-To-Use Carfilzomib Compositions
#282THERAPEUTIC NANOCONJUGATES AND USES THEREOF
#283Methods and compositions for delivery of biotin to mitochondria
#284LIGAND-DRUG-CONJUGATES AS SUBSTRATES FOR SELECTIVE CLEAVAGE BY THE EXOPEPTIDASE ACTIVITY OF CATHEPSIN B
#285Anti-mesothelin antibody and antibody drug conjugate thereof
#286ANTIBODY-DRUG CONJUGATES
#287Methods and compositions for the treatment of Sengers syndrome
#288METHODS AND COMPOSITIONS FOR THE TREATMENT OF OPIOID DEPENDENCE AND FOR THE TREATMENT OF PAIN
#289SALT AND CRYSTALLINE FORMS OF RAPASTINEL
#290Sulfomaleimide-based linkers and corresponding conjugates
#291GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#292PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY
#293METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS
#294METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY
#295Stable antibody-drug conjugate, preparation method therefor, and use thereof
#296Methods and compositions for the prevention or treatment of Barth syndrome
#297AGENTS THAT INHIBIT NGLY1 AND METHODS OF USE THEREOF
#298Sulfatase-cleavable linkers for antibody-drug conjugates
#299Method for producing antibody-drug conjugate intermediate by addition of acid and use thereof
#300Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereof